These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 7647082)

  • 21. Plasma prolactin and central D2 receptor occupancy in antipsychotic drug-treated patients.
    Nordström AL; Farde L
    J Clin Psychopharmacol; 1998 Aug; 18(4):305-10. PubMed ID: 9690696
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Use of haloperidol in high doses in schizophrenia. Clinical, biochemical and pharmacokinetic study].
    Scatton B; Zarifian E; Bianchetti G; Cuche H; Loo H; Morselli PL
    Encephale; 1982; 8(1):1-8. PubMed ID: 7094868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetic protocol for predicting plasma haloperidol concentrations.
    Miller DD; Perry PJ; Kelly MW; Coryell WH; Arndt SV
    J Clin Psychopharmacol; 1990 Jun; 10(3):207-12. PubMed ID: 2376619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The new selective D2-dopamine receptor antagonist raclopride--pharmacokinetics, safety and tolerability in healthy males.
    Farde L; von Bahr C; Wahlen A; Nilsson L; Widman M
    Int Clin Psychopharmacol; 1989 Apr; 4(2):115-26. PubMed ID: 2526172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of carbamazepine on the pharmacokinetics of paliperidone extended-release tablets at steady-state.
    Kerbusch-Herben V; Cleton A; Berwaerts J; Vandebosch A; Remmerie B
    Clin Pharmacol Drug Dev; 2014 Sep; 3(5):371-7. PubMed ID: 27129010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid elimination of quinidine in pediatric patients.
    Szefler SJ; Pieroni DR; Gingell RL; Shen DD
    Pediatrics; 1982 Sep; 70(3):370-5. PubMed ID: 7110810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Steady state pharmacokinetics of tiaprofenic acid in elderly patients.
    Nilsen OG; Jacobsen G; Walstad RA
    Arzneimittelforschung; 1985; 35(5):875-9. PubMed ID: 4026913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interconversions between haloperidol and reduced haloperidol in schizophrenic patients and guinea pigs: a steady-state study.
    Chang WH; Lin SK; Jann MW
    J Clin Psychopharmacol; 1991 Apr; 11(2):99-105. PubMed ID: 2056148
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of diclofenac and five metabolites after single doses in healthy volunteers and after repeated doses in patients.
    Degen PH; Dieterle W; Schneider W; Theobald W; Sinterhauf U
    Xenobiotica; 1988 Dec; 18(12):1449-55. PubMed ID: 3245235
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma levels of benperidol, prolactin, and homovanillic acid after intravenous versus two different kinds of oral application of the neuroleptic in schizophrenic patients.
    Seiler W; Wetzel H; Hillert A; Schöllnhammer G; Benkert O; Hiemke C
    Exp Clin Endocrinol; 1994; 102(4):326-33. PubMed ID: 7813605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacology, pharmacokinetics and clinical development of haloperidol decanoate.
    Gelders YG
    Int Clin Psychopharmacol; 1986 Jul; 1 Suppl 1():1-11. PubMed ID: 3559159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of a sustained release formulation of pyridoxal phosphate of buflomedil after single or repeated oral doses in healthy volunteers.
    de Bernardi di Valserra M; Germogli R; Feletti F; Covini D; Borgonovo E
    Arzneimittelforschung; 1992 May; 42(5):632-6. PubMed ID: 1530676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term depot neuroleptic treatment with perphenazine decanoate. II. Different depot intervals in the last 6 months of a 12 month study of 42 drug monitored psychotic patients.
    Knudsen P; Hansen LB; Højholdt K; Larsen NE
    Acta Psychiatr Scand Suppl; 1985; 322():41-50. PubMed ID: 3934921
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of an oral controlled release formulation of remoxipride: a double-blind, crossover comparison with conventional formulation in chronic schizophrenics.
    Soni SD; Tench D; Ashwood TJ; Movin G
    Acta Psychiatr Scand Suppl; 1990; 358():45-7. PubMed ID: 1978487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oxytetracycline pharmacokinetics, tissue depletion, and toxicity after administration of a long-acting preparation at double the label dosage.
    TerHune TN; Upson DW
    J Am Vet Med Assoc; 1989 Apr; 194(7):911-7. PubMed ID: 2703423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The relationship between plasma and red blood cell neuroleptic levels, oral dosage, and clinical parameters in a chronic schizophrenic population.
    Dunlop SR; Shea PA; Hendrie HC
    Biol Psychiatry; 1982 Aug; 17(8):929-36. PubMed ID: 6126231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Depot neuroleptic therapy: clinical considerations.
    Remington GJ; Adams ME
    Can J Psychiatry; 1995 Apr; 40(3 Suppl 1):S5-11. PubMed ID: 7627927
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy, safety and tolerability of raclopride, a specific D2 receptor blocker, in acute schizophrenia: an open trial.
    Cookson JC; Natorf B; Hunt N; Silverstone T; Uppfeldt G
    Int Clin Psychopharmacol; 1989 Jan; 4(1):61-70. PubMed ID: 2531773
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Altered methadone pharmacokinetics in pregnancy: implications for dosing.
    Swift RM; Dudley M; DePetrillo P; Camara P; Griffiths W
    J Subst Abuse; 1989; 1(4):453-60. PubMed ID: 2485290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Initial results of a pharmacokinetic study of pipothiazine and its palmitic ester (Piportil L4) in a schizophrenic population].
    Girard M; Granier F; Schmitt L; Cotonat J; Escande M; Blanc M
    Encephale; 1984; 10(4):171-6. PubMed ID: 6149927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.